This grant is for supporting the rapid implementation of clinical trials with the potential to significantly impact diseases or conditions addressed in FY12 PRMRP topic areas. The DoD Peer Reviewed Medical Clinical Trial Award funds projects evaluating promising new products, pharmacologic agents, devices, clinical guidance, and emerging technologies. Projects range from small proof-of-concept trials (e.g., pilot, first in human) to large-scale efficacy studies in relevant patient populations. All studies must be responsive to the healthcare needs of military service members, veterans, and/or beneficiaries, though military population use is not required. This grant aims to accelerate medical advancements for this community.
Opportunity ID: 159913
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-PRMRP-CTA |
| Funding Opportunity Title: | DoD Peer Reviewed Medical Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 29, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jun 26, 2012 |
| Current Closing Date for Applications: | Jun 26, 2012 |
| Archive Date: | Jul 26, 2012 |
| Estimated Total Program Funding: | $6,600,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY12 PRMRP topic areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proofof- concept (i.e., pilot, first in human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the health care needs of the military service members, veterans, and/or beneficiaries; however, the use of military populations is not required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 159913 Full Announcement-1 -> fy12 cta ind documentation form.pdf
Folder 159913 Full Announcement-1 -> w81xwh-12-prmrp-cta.pdf
Packages
| Agency Contact Information: | 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00112250 | Mar 29, 2012 | Jun 26, 2012 | View |
Package 1
Mandatory forms
159913 RR_SF424_1_2-1.2.pdf
159913 PerformanceSite_1_4-1.4.pdf
159913 RR_Budget-1.1.pdf
159913 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
159913 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
